---
title: "Cannabis Bioscience International Holdings, Inc. (CBIH.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CBIH.US.md"
symbol: "CBIH.US"
name: "Cannabis Bioscience International Holdings, Inc."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-20T12:25:38.861Z"
locales:
  - [en](https://longbridge.com/en/quote/CBIH.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CBIH.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CBIH.US.md)
---

# Cannabis Bioscience International Holdings, Inc. (CBIH.US)

## Company Overview

Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. It is also involved in clinical trials and medical research services through its Alpha Research Institute; and sale of CBD products.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: C (0.59)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 41 / 59 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -64.05% |  |
| Net Profit YoY | -8.94% |  |
| P/B Ratio | -2.00 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2931687.34 |  |
| Revenue | 123627.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 38.27% | A |
| Profit Margin | -416.81% | E |
| Gross Margin | 72.82% | A |
| Revenue YoY | -64.05% | E |
| Net Profit YoY | -8.94% | D |
| Total Assets YoY | -89.63% | E |
| Net Assets YoY | -19.71% | E |
| Cash Flow Margin | 52.03% | C |
| OCF YoY | -64.05% | E |
| Turnover | 15.05 | A |
| Gearing Ratio | 95121.37% | E |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Cannabis Bioscience International Holdings, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-64.05%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-8.94%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "-2.00",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "2931687.34",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "123627.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "38.27%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-416.81%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "72.82%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "-64.05%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "-8.94%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-89.63%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-19.71%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "52.03%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "-64.05%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "15.05",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "95121.37%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -5.69 | 41/59 | - | - | - |
| PB | -2.00 | 55/59 | - | - | - |
| PS (TTM) | 23.71 | 56/59 | 41.08 | 31.35 | 17.27 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | ChromaDex (CDXC.US) | A | A | A | B | A | A |
| 02 | Agilent Tech (A.US) | A | C | B | C | C | B |
| 03 | West Pharmaceutical (WST.US) | B | B | B | B | B | B |
| 04 | Illumina (ILMN.US) | A | C | B | D | C | B |
| 05 | WuXi Biologics (WXXWY.US) | B | B | C | A | B | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CBIH.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CBIH.US/norm.md)
- [Related News](https://longbridge.com/en/quote/CBIH.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CBIH.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**